$26.530
+0.740 (+2.79%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RARE 相似图表分析预测
Alphio's RARE stock price prediction model matches the current Ultragenyx Pharmaceutical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.45 (-2.68%). The 1-week path is $14.54 (-2.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Ultragenyx Pharmaceutical Inc 股票吗？
Ultragenyx Pharmaceutical Inc. (RARE) is a good buy right now due to its recent FDA accelerated approval for GENGLYCOS, which is expected to significantly enhance revenue potential. The current price is $25.61, and analysts have set price targets as high as $103, indicating substantial upside potential. Additionally, the gross margin stands at 84.11%, reflecting strong profitability potential despite current losses. However, the main risk is the negative net income, which was -92 million USD in the latest quarter, indicating ongoing financial challenges.
RARE 股价于 Wednesday 收于 $26.53，此前上涨 +2.79%
Ultragenyx Pharmaceutical Inc (RARE) last closed at $14.85, losing -44.03%. These facts feed the 1-day and 1-week RARE price prediction above.
分析师一致预期
Ultragenyx Pharmaceutical Inc（RARE）：买入 10、持有 7、卖出 1。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Ultragenyx Pharmaceutical Inc（RARE）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 RARE 最接近的股票，按相似度排序。
RARE 季节性分析
Historically the probability of a positive September return for RARE is 50.00%. August offers the highest probability of a positive month at 65.62%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
RARE 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Sep 2026 | $37.62 | $41.80 | $47.67 | +181.47% |
| Oct 2026 | $43.78 | $51.74 | $56.68 | +248.42% |
| Nov 2026 | $50.96 | $51.74 | $51.97 | +248.42% |
| Dec 2026 | $49.40 | $49.73 | $52.29 | +234.89% |
2026 年，Ultragenyx Pharmaceutical Inc（RARE）预计区间为 $37.62 至 $56.68。
Ultragenyx Pharmaceutical Inc 2026 年月度预测
2026 年 Sep，Ultragenyx Pharmaceutical Inc 预计均价 $41.80，最低 $37.62，最高 $47.67。
2026 年 Oct，Ultragenyx Pharmaceutical Inc 预计均价 $51.74，最低 $43.78，最高 $56.68。
2026 年 Nov，Ultragenyx Pharmaceutical Inc 预计均价 $51.74，最低 $50.96，最高 $51.97。
2026 年 Dec，Ultragenyx Pharmaceutical Inc 预计均价 $49.73，最低 $49.40，最高 $52.29。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。